FT-104
Pre-clinical- Indications
- Treatment Resistant Depression, Postpartum Depression
Company intelligence / Profile preview
Field Trip Health was one of North America's largest providers of legal psychedelic-assisted therapies—primarily ketamine—for depression, anxiety, and PTSD. Clinical results reported significant improvements in depression/anxiety scores lasting up to six months after four to six sessions. The company also launched online integration therapy covered by major insurers.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Field Trip Health.